NIMI
GILD icon

Natixis Investment Managers International’s Gilead Sciences GILD Stock Holding History

Natixis Investment Managers International’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-77,871
Closed -$4.81M – 322
2022
Q2 		$4.81M Buy
77,871
+14,946
+24% +$925K 0.1% 66
2022
Q1 		$3.74M Buy
+62,925
New +$4.02M 0.07% 79
2018
Q4 		– Sell
-282,744
Closed -$21.8M – 244
2018
Q3 		$21.8M Buy
282,744
+40,440
+17% +$3.05M 1.02% 19
2018
Q2 		$17.2M Buy
242,304
+7,269
+3% +$513K 0.94% 20
2018
Q1 		$17.7M Buy
235,035
+157,305
+202% +$12.5M 1.27% 19
2017
Q4 		$5.57M Sell
77,730
-17,921
-19% -$1.36M 0.62% 38
2017
Q3 		$7.75M Buy
95,651
+13,130
+16% +$1M 0.67% 36
2017
Q2 		$5.84M Buy
82,521
+9,627
+13% +$641K 0.51% 40
2017
Q1 		$4.95M Sell
72,894
-574
-0.8% -$40.4K 0.44% 46
2016
Q4 		$5.26M Sell
73,468
-591
-0.8% -$43.9K 0.5% 43
2016
Q3 		$5.86M Buy
74,059
+11,061
+18% +$899K 0.6% 40
2016
Q2 		$5.25M Buy
62,998
+8,041
+15% +$714K 0.57% 42
2016
Q1 		$5.05M Sell
54,957
-477
-0.9% -$43K 0.6% 42
2015
Q4 		$5.61M Sell
55,434
-165
-0.3% -$17.2K 0.73% 36
2015
Q3 		$5.46M Buy
55,599
+11,652
+27% +$1.29M 0.74% 33
2015
Q2 		$5.15M Buy
43,947
+1,761
+4% +$192K 0.63% 37
2015
Q1 		$4.14M Buy
42,186
+20,989
+99% +$2.13M 0.53% 43
2014
Q4 		$2M Buy
21,197
+19,424
+1,096% +$2.01M 0.26% 67
2014
Q3 		$189K Sell
1,773
-1,546
-47% -$151K 0.03% 163
2014
Q2 		$275K Sell
3,319
-3,181
-49% -$248K 0.04% 169
2014
Q1 		$461K Hold
6,500
– – 0.06% 123
2013
Q4 		$488K Sell
6,500
-500
-7% -$34.8K 0.09% 106
2013
Q3 		$440K Hold
7,000
– – 0.1% 94
2013
Q2 		$359K Buy
+7,000
New +$365K 0.08% 90

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Natixis Investment Managers International's GILD Position: Q3 2022 in Review

Natixis Investment Managers International sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 77,871 shares — an estimated $4.81M sold.

Natixis Investment Managers International first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $21.8M in Q3 2018. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Natixis Investment Managers International reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 77,871 Gilead Sciences shares in Q3 2022, an estimated $4.81M.
  • Natixis Investment Managers International first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
  • Natixis Investment Managers International's Gilead Sciences position peaked at $21.8M in Q3 2018.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.